The Clinical Epidemiology of Scrub Typhus in Humans, Chiggers and Rodents
1 other identifier
observational
1,200
0 countries
N/A
Brief Summary
This study to collect and identify rodents and mites across transects through diverse habitats used by the human community from a localised area identified as a scrub typhus 'hot spot'.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2016
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 18, 2016
CompletedFirst Posted
Study publicly available on registry
August 23, 2016
CompletedStudy Start
First participant enrolled
September 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 10, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2018
CompletedSeptember 29, 2021
September 1, 2021
1.6 years
August 18, 2016
September 28, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
determine the diversity of O. tsutsugamushi genotypes infecting rodents and mites and link these to their geographical distribution and associated habitat characteristics.
up to 24 months
Correlate the frequency of O. tsutsugamushi in mites and rodents with habitat characteristics, to define interactions between distribution and transmission dynamics.
up to 24 months
Identify key mite vectors and rodent hosts involved in scrub typhus natural history, human infection, and disease virulence
up to 24 months
Secondary Outcomes (4)
Determine changes in scrub typhus antibody titres over time and identify acutely infected scrub typhus cases
up to 24 months
Identify human-derived O. tsutsugamushi genotypes to define genomic relationships between human, rodent and mite-derived genotypes.
up to 24 months
Identify putative determinants of human infection/virulence
up to 24 months
To interlink the distribution of O. tsutsugamushi positive mites, rodents and humans with habitat characteristics to propose interventions to reduce the risk of human disease.
up to 24 months
Study Arms (2)
Acute scrub typhus (Group 1)
Participants presenting with a fever will be verbally consented for a scrub typhus RDT, using \<1ml of blood that is likely to be taken as part of routine clinical assessment. If the RDT tests positive, the patient will be informed about the study and asked to give written informed consent. If they agree to join the study, participants will be asked to give a further blood sample of 10mls (2 teaspoons) for ELISA, PCR and culture testing to confirm the presence of scrub typhus.
Scrub typhus serosurvey (Group 2)
Villagers who are living in an identified scrub typhus environment will be informed about the study and asked to give written informed consent. If they agree to join the study they will be asked to give a finger prick dried blood spot (DBS) test on which scrub typhus ELISA and IFA will be performed.
Eligibility Criteria
Group 1 Male or Female, aged 10 years or above, presenting with a fever Group 2 Male or Female, aged 10 years or above, living in an identified scrub typhus environment
You may qualify if:
- Acute scrub typhus (Group 1)
- Presenting with fever \>38 C and testing positive by scrub typhus RDT.
- Male or Female, aged 10 years or above.
- Participant is willing and able to give informed consent for participation in the study.
- Scrub typhus serosurvey (Group 2)
- Villagers living in an environment in which scrub typhus is known to be present, who are asymptomatic.
- Male or Female, aged 10 years or above.
- Participant is willing and able to give informed consent for participation in the study.
You may not qualify if:
- Acute scrub typhus (Group 1)
- Villagers/patients under 10 years of age.
- Those unwilling to give written informed consent.
- Scrub typhus serosurvey (Group 2)
- Villagers/patients under 10 years of age.
- Those unwilling to give written informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Oxfordlead
- Mahidol Oxford Tropical Medicine Research Unitcollaborator
- Lao-Oxford-Mahosot Hospital Wellcome Trust Research Unitcollaborator
- Wellcome Trustcollaborator
- Centre National de la Recherche Scientifique, Francecollaborator
Biospecimen
Group 1: 10 ml of blood will be collected from the participant. Group 2: 0.2 ml of blood will be collected from the participant.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 18, 2016
First Posted
August 23, 2016
Study Start
September 1, 2016
Primary Completion
April 10, 2018
Study Completion
December 31, 2018
Last Updated
September 29, 2021
Record last verified: 2021-09
Data Sharing
- IPD Sharing
- Will share